BSD Medical Corporation (NASDAQ:BSDM) jumped 45.51% up to $2.43 on news the Journal of the National Cancer Institute published an article on the evolving role of hyperthermia in cancer therapy titled, “International Study of Hyperthermia Spurs Hope in U.S.” The article stated that, “Successful use of targeted heat therapy with chemotherapy in treatment of soft-tissue sarcoma has given US advocates of local hyperthermia new hope that the treatment they so believe in will now be taken seriously.” Last fall a Phase III study, which applied the BSD-2000 Hyperthermia System, showed that patients with high risk soft-tissue sarcomas were 30% more likely to be alive and cancer free almost three years after beginning the treatment if heat therapy was added to chemotherapy. Headquartered in Salt Lake City, Utah, BSD Medical Corporation develops, manufactures, commercializes, and services systems used for therapeutic treatments of cancer and other diseases.   The company is specialized in researching and developing therapeutics which bio-enhance current treatments.

Repros Therapeutics Inc. (NASDAQ:RPRX) gained 25.97% up to $0.94 on news the company has received verbal confirmation from the Division of Metabolic and Endocrine Drug Products of the Food and Drug Agency that the company may begin its Investigational New Drug Application for the study of oral Androxal in the treatment of hypogonadal men with Type II Diabetes with a Phase IIa trial. Based in The Woodlands, Texas, Repros Therapeutics is a development-stage biopharmaceutical company developing drug therapies for the treatment of serious female pelvic conditions, such as treatment of uterine fibroids, anaemia associated with excessive menstrual bleeding relating to uterine fibroids, and anaemia associated with uterine fibroids and endometriosis.  Repros Therapeutics has three late stage drug candidates in trials including Androxal, a hormone treatment of for low testosterone levels in men.  RPRX is surging on heavy volume with 9,067,032 shares trading actively.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

Related posts:

1. RPRX Surges 57 Percent On FDA Guidance RPRX up 57.74% on guidance from the Division of Reproductive...
2. Biotech And Biopharmaceutical Solutions Make Strong Gains In Late Morning Pro-Dex, Inc. jumped 27.66% boasting gross profits for the quarter...
3. QLTI Jumps On Settlement QLT will pay $20 million to the Massachusetts General Hospital...
4. Repros Stock Surges On Positive Trial Results Repros Therapeutics Inc. skyrocketed 124.73% on news disclosed late yesterday,...
5. BSD Medical And VeriChip Corporation Are Early Morning Gainers In Biotechnology The potential ultimate application of RFID chips is much broader...

Related posts brought to you by Yet Another Related Posts Plugin.